Effect of acute environmental hypoxia on protein metabolism in human skeletal muscle

Acta Physiologica

Volumn 208, Issue 3, 2013, Pages 251-264

  D'Hulst, G ^a   Jamart, C ^b   Van Thienen, R ^a   Hespel, P ^a   Francaux, M ^b   Deldicque, L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Insulin; NIRS; PKB; Proteasome; S6K1

Indexed keywords

CALPAIN; CARBOHYDRATE; CATHEPSIN L; FAT; GLUCOSE; HEMOGLOBIN; HYDROCORTISONE; HYPOXIA INDUCIBLE FACTOR 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MUSCLE PROTEIN; MYOGLOBIN; OXYGEN; PROTEASOME; PROTEIN;

ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENVIRONMENTAL HYPOXIA; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOXIA; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; MALE; MEAL; MUSCLE ATROPHY; MUSCLE BIOPSY; NORMAL HUMAN; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SKELETAL MUSCLE; TISSUE OXYGENATION; UPREGULATION; WESTERN BLOTTING;

ACUTE DISEASE; ANOXIA; ATMOSPHERE EXPOSURE CHAMBERS; BLOOD GLUCOSE; BREAKFAST; CALPAIN; CATHEPSIN L; CROSS-OVER STUDIES; HUMANS; HYDROCORTISONE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; OXIMETRY; OXYGEN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SKP CULLIN F-BOX PROTEIN LIGASES; TOR SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84879347800     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12086     Document Type: Article

References (57)

1. Ameln, H., Gustafsson, T., Sundberg, C.J., Okamoto, K., Jansson, E., Poellinger, L. & Makino, Y. 2005. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J 19, 1009-1011.
2. Arsham, A.M., Howell, J.J. & Simon, M.C. 2003. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 278, 29655-29660.
3. Atherton, P.J. & Smith, K. 2012. Muscle protein synthesis in response to nutrition and exercise. J Physiol 590, 1049-1057.
4. Baldi, S., Aquilani, R., Pinna, G.D., Poggi, P., De Martini, A. & Bruschi, C. 2010. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis 5, 29-39.
5. Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., Poueymirou, W.T., Panaro, F.J., Na, E., Dharmarajan, K., Pan, Z.Q., Valenzuela, D.M., DeChiara, T.M., Stitt, T.N., Yancopoulos, G.D. & Glass, D.J. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
6. Cam, H., Easton, J.B., High, A. & Houghton, P.J. 2010. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha. Mol Cell 40, 509-520.
7. Chaudhary, P., Suryakumar, G., Prasad, R., Singh, S.N., Ali, S. & Ilavazhagan, G. 2012. Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin-proteasome pathway and calpains. Mol Cell Biochem 364, 101-113.
8. Deldicque, L., Cani, P.D., Philp, A., Raymackers, J.M., Meakin, P.J., Ashford, M.L., Delzenne, N.M., Francaux, M. & Baar, K. 2010a. The unfolded protein response is activated in skeletal muscle by high-fat feeding: potential role in the downregulation of protein synthesis. Am J Physiol Endocrinol Metab 299, E695-E705.
9. Deldicque, L., De Bock, K., Maris, M., Ramaekers, M., Nielens, H., Francaux, M. & Hespel, P. 2010b. Increased p70s6k phosphorylation during intake of a protein-carbohydrate drink following resistance exercise in the fasted state. Eur J Appl Physiol 108, 791-800.
10. DeYoung, M.P., Horak, P., Sofer, A., Sgroi, D. & Ellisen, L.W. 2008. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 22, 239-251.
11. Drogat, B., Auguste, P., Nguyen, D.T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R.J., Chevet, E., Bikfalvi, A. & Moenner, M. 2007. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res 67, 6700-6707.
12. Etheridge, T., Atherton, P.J., Wilkinson, D., Selby, A., Rankin, D., Webborn, N., Smith, K. & Watt, P.W. 2011. Effects of hypoxia on muscle protein synthesis and anabolic signaling at rest and in response to acute resistance exercise. Am J Physiol Endocrinol Metab 301, E697-E702.
13. Favier, F.B., Costes, F., Defour, A., Bonnefoy, R., Lefai, E., Bauge, S., Peinnequin, A., Benoit, H. & Freyssenet, D. 2010. Downregulation of Akt/mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia. Am J Physiol Regul Integr Comp Physiol 298, R1659-R1666.
14. Ferrari, M., Mottola, L. & Quaresima, V. 2004. Principles, techniques, and limitations of near infrared spectroscopy. Can J Appl Physiol 29, 463-487.
15. Frost, R.A., Huber, D., Pruznak, A. & Lang, C.H. 2009. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes. J Cell Biochem 108, 1192-1202.
16. Garvey, J.F., Taylor, C.T. & McNicholas, W.T. 2009. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33, 1195-1205.
17. Gingras, A.C., Gygi, S.P., Raught, B., Polakiewicz, R.D., Abraham, R.T., Hoekstra, M.F., Aebersold, R. & Sonenberg, N. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13, 1422-1437.
18. Gingras, A.C., Raught, B., Gygi, S.P., Niedzwiecka, A., Miron, M., Burley, S.K., Polakiewicz, R.D., Wyslouch-Cieszynska, A., Aebersold, R. & Sonenberg, N. 2001. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15, 2852-2864.
19. Greenhaff, P.L., Karagounis, L.G., Peirce, N., Simpson, E.J., Hazell, M., Layfield, R., Wackerhage, H., Smith, K., Atherton, P., Selby, A. & Rennie, M.J. 2008. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab 295, E595-E604.
20. Greer, S.N., Metcalf, J.L., Wang, Y. & Ohh, M. 2012. The updated biology of hypoxia-inducible factor. EMBO J 31, 2448-2460.
21. Grocott, M., Montgomery, H. & Vercueil, A. 2007. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit Care 11, 203.
22. Hoppeler, H., Kleinert, E., Schlegel, C., Claassen, H., Howald, H., Kayar, S.R. & Cerretelli, P. 1990. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J Sports Med 11(Suppl 1), S3-S9.
23. Jackman, R.W. & Kandarian, S.C. 2004. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287, C834-C843.
24. Jamart, C., Francaux, M., Millet, G.Y., Deldicque, L., Frere, D. & Feasson, L. 2012. Modulation of autophagy and ubiquitin-proteasome pathways during ultra-endurance running. J Appl Physiol 112, 1529-1537.
25. Jamart, C., Raymackers, J.M., Li, A.G., Deldicque, L. & Francaux, M. 2011. Prevention of muscle disuse atrophy by MG132 proteasome inhibitor. Muscle Nerve 43, 708-716.
26. Koritzinsky, M., Magagnin, M.G., van den Beucken, T., Seigneuric, R., Savelkouls, K., Dostie, J., Pyronnet, S., Kaufman, R.J., Weppler, S.A., Voncken, J.W., Lambin, P., Koumenis, C., Sonenberg, N. & Wouters, B.G. 2006. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 25, 1114-1125.
27. Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Diehl, A., Sonenberg, N., Koromilas, A. & Wouters, B.G. 2002. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 22, 7405-7416.
28. Koumenis, C. & Wouters, B.G. 2006. "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res 4, 423-436.
29. Lacey, R.J., Cable, H.C., James, R.F., London, N.J., Scarpello, J.H. & Morgan, N.G. 1993. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans. J Endocrinol 138, 555-563.
30. Laplante, M. & Sabatini, D.M. 2012. mTOR signaling in growth control and disease. Cell 149, 274-293.
31. Larsen, J.J., Hansen, J.M., Olsen, N.V., Galbo, H. & Dela, F. 1997. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504(Pt 1), 241-249.
32. Lee, W.H., Kim, Y.W., Choi, J.H., Brooks, S.C. III, Lee, M.O. & Kim, S.G. 2009. Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect. Mol Cancer Ther 8, 2791-2802.
33. Liu, L., Cash, T.P., Jones, R.G., Keith, B., Thompson, C.B. & Simon, M.C. 2006. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell 21, 521-531.
34. Lundby, C., Pilegaard, H., Andersen, J.L., van Hall, G., Sander, M. & Calbet, J.A. 2004. Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscle. J Exp Biol 207, 3865-3871.
35. MacDougall, J.D., Green, H.J., Sutton, J.R., Coates, G., Cymerman, A., Young, P. & Houston, C.S. 1991. Operation Everest II: structural adaptations in skeletal muscle in response to extreme simulated altitude. Acta Physiol Scand 142, 421-427.
36. Martin, D.S., Levett, D.Z., Mythen, M. & Grocott, M.P. 2009. Changes in skeletal muscle oxygenation during exercise measured by near-infrared spectroscopy on ascent to altitude. Crit Care 13(Suppl 5), S7.
37. Masschelein, E., Van Thienen, R., Wang, X., Van Schepdael, A., Thomis, M. & Hespel, P. 2012. Dietary nitrate improves muscle but not cerebral oxygenation status during exercise in hypoxia. J Appl Physiol 113, 736-745.
38. Mazzeo, R.S., Wolfel, E.E., Butterfield, G.E. & Reeves, J.T. 1994. Sympathetic response during 21 days at high altitude (4, 300 m) as determined by urinary and arterial catecholamines. Metabolism 43, 1226-1232.
39. McGee, S.L. & Hargreaves, M. 2010. AMPK-mediated regulation of transcription in skeletal muscle. Clin Sci (Lond) 118, 507-518.
40. Mizuno, M., Savard, G.K., Areskog, N.H., Lundby, C. & Saltin, B. 2008. Skeletal muscle adaptations to prolonged exposure to extreme altitude: a role of physical activity? High Alt Med Biol 9, 311-317.
41. Navegantes, L.C., Resano, N.M., Baviera, A.M., Migliorini, R.H. & Kettelhut, I.C. 2004. Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 286, E642-E647.
42. Navegantes, L.C., Resano, N.M., Migliorini, R.H. & Kettelhut, I.C. 2000. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab 279, E663-E668.
43. Ordway, G.A. & Garry, D.J. 2004. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 207, 3441-3446.
44. Oyadomari, S. & Mori, M. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11, 381-389.
45. Ron, D. & Walter, P. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8, 519-529.
46. Schols, A.M., Broekhuizen, R., Weling-Scheepers, C.A. & Wouters, E.F. 2005. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82, 53-59.
47. Schwarzer, R., Tondera, D., Arnold, W., Giese, K., Klippel, A. & Kaufmann, J. 2005. REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene 24, 1138-1149.
48. Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., Kalinski, H., Kamer, I., Rozen, A., Mor, O., Keshet, E., Leshkowitz, D., et al. 2002. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22, 2283-2293.
49. Stitt, T.N., Drujan, D., Clarke, B.A., Panaro, F., Timofeyva, Y., Kline, W.O., Gonzalez, M., Yancopoulos, G.D. & Glass, D.J. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14, 395-403.
50. Tagliavacca, L., Caretti, A., Bianciardi, P. & Samaja, M. 2012. In vivo up-regulation of the unfolded protein response after hypoxia. Biochim Biophys Acta 1820, 900-906.
51. Tracy, K., Dibling, B.C., Spike, B.T., Knabb, J.R., Schumacker, P. & Macleod, K.F. 2007. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 27, 6229-6242.
52. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. & Speleman, F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
53. Vigano, A., Ripamonti, M., De Palma, S., Capitanio, D., Vasso, M., Wait, R., Lundby, C., Cerretelli, P. & Gelfi, C. 2008. Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia. Proteomics 8, 4668-4679.
54. Vincent, B., Windelinckx, A., Nielens, H., Ramaekers, M., Van Leemputte, M., Hespel, P. & Thomis, M.A. 2010. Protective role of alpha-actinin-3 in the response to an acute eccentric exercise bout. J Appl Physiol 109, 564-573.
55. Whitney, M.L., Jefferson, L.S. & Kimball, S.R. 2009. ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression. Biochem Biophys Res Commun 379, 451-455.
56. Wouters, B.G. & Koritzinsky, M. 2008. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8, 851-864.
57. Wust, R.C. & Degens, H. 2007. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2, 289-300.